NCT05104697 - TMS for Improving Response Inhibition in Adolescents With OCD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

August 1, 2023

Study Completion Date

September 1, 2023

Conditions

Obsessive-Compulsive Disorder

Interventions

DEVICE

Transcranial Magnetic Stimulation

All teens will receive active TMS; they will be randomly assigned to receive active TMS at either visit 1 or visit 2 (order counterbalanced)

Trial Locations (1)

Emma Pendleton Bradley Hospital, Riverside